These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Persistent fetal sinus bradycardia associated with maternal anti-SSA/Ro and anti-SSB/La antibodies. Chockalingam P; Jaeggi ET; Rammeloo LA; Haak MC; Adama van Scheltema PN; Breur JM; Bartelings MM; Clur SA; Blom NA J Rheumatol; 2011 Dec; 38(12):2682-5. PubMed ID: 22089457 [TBL] [Abstract][Full Text] [Related]
31. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. Sonesson SE; Salomonsson S; Jacobsson LA; Bremme K; Wahren-Herlenius M Arthritis Rheum; 2004 Apr; 50(4):1253-61. PubMed ID: 15077309 [TBL] [Abstract][Full Text] [Related]
32. [Congenital atrioventricular block]. Grolleau R; Leclercq F; Guillaumont S; Voisin M Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():47-55. PubMed ID: 10326158 [TBL] [Abstract][Full Text] [Related]
33. Maternal predictive factors for fetal congenital heart block in pregnant mothers positive for anti-SS-A antibodies. Tsuboi H; Sumida T; Noma H; Yamagishi K; Anami A; Fukushima K; Horigome H; Maeno Y; Kishimoto M; Takasaki Y; Nakayama M; Waguri M; Sago H; Murashima A Mod Rheumatol; 2016 Jul; 26(4):569-75. PubMed ID: 26457409 [TBL] [Abstract][Full Text] [Related]
34. [A case of neonatal lupus syndrome and congenital atrioventricular block associated with maternal antibodies antiRo/SS-A]. De Leonibus C; Lembo C; Giliberti P; Rojo S; Foglia MC; Giordano L; Fratta A Minerva Pediatr; 2012 Apr; 64(2):251-6. PubMed ID: 22495199 [TBL] [Abstract][Full Text] [Related]
35. First-degree heart block in the fetus of an anti-SSA/Ro-positive mother: reversal after a short course of dexamethasone treatment. Vesel S; Mazić U; Blejec T; Podnar T Arthritis Rheum; 2004 Jul; 50(7):2223-6. PubMed ID: 15248221 [TBL] [Abstract][Full Text] [Related]
36. Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies. Sonesson SE; Hedlund M; Ambrosi A; Wahren-Herlenius M Rheumatology (Oxford); 2017 Oct; 56(10):1755-1762. PubMed ID: 28957562 [TBL] [Abstract][Full Text] [Related]
37. The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block. Fesslova V; Vignati G; Brucato A; De Sanctis M; Butera G; Pisoni MP; Chiappa E; Acaia B; Meroni PL Cardiol Young; 2009 Jun; 19(3):282-90. PubMed ID: 19383179 [TBL] [Abstract][Full Text] [Related]
38. [Successful intrauterine digoxin therapy for fetal complete atrioventricular block with endocardial cushion defect: a case report]. Ishikawa S; Yin J; Maeda H; Satoh S; Takeuchi A; Yasui H; Koyanagi T; Nakano H Fukuoka Igaku Zasshi; 1992 Jul; 83(7):315-8. PubMed ID: 1398424 [TBL] [Abstract][Full Text] [Related]
39. [Congenital complete atrioventricular block in children: pathogenesis and clinical outcomes]. Udink ten Cate FE; Breur JM; van Woerkom JM; Kruize AA; Stoutenbeek P; Meijboom EJ Ned Tijdschr Geneeskd; 2002 Sep; 146(38):1777-81. PubMed ID: 12369438 [TBL] [Abstract][Full Text] [Related]
40. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]